ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
143,300
+2,200 (1.56%)
Apr 10, 2026, 3:30 PM KST

ST Pharm Revenue

In the year 2025, ST Pharm had annual revenue of 331.68B KRW with 21.16% growth. ST Pharm had revenue of 129.10B in the quarter ending December 31, 2025, with 11.55% growth.

Revenue
331.68B
Revenue Growth
+21.16%
P/S Ratio
8.86
Revenue / Employee
506.38M
Employees
655
Market Cap
2.94T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025331.68B57.93B21.16%
Dec 31, 2024273.75B-11.24B-3.94%
Dec 31, 2023284.99B35.67B14.31%
Dec 31, 2022249.32B83.68B50.52%
Dec 31, 2021165.64B41.53B33.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Samsung Biologics4.56T
Celltrion4.16T
Samsung Epis Holdings3.02T
Hanmi Science1.36T
SK bioscience651.37B
PharmaResearch536.29B
Hugel425.11B
ALTEOGEN215.86B
Revenue Rankings